CPIX - Cumberland Pharmaceuticals Inc.
IEX Last Trade
1.385
0.025 1.805%
Share volume: 3,606
Last Updated: Fri 30 Aug 2024 09:58:53 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$1.36
0.03
1.84%
Fundamental analysis
16%
Profitability
0%
Dept financing
43%
Liquidity
75%
Performance
10%
Performance
5 Days
-2.17%
1 Month
-8.78%
3 Months
-6.90%
6 Months
-38.64%
1 Year
-19.64%
2 Year
-41.56%
Key data
Stock price
$1.38
DAY RANGE
N/A - N/A
52 WEEK RANGE
$1.32 - $2.36
52 WEEK CHANGE
-$0.19
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
Company detail
CEO:
Region: US
Website: cumberlandpharma.com
Employees: 99
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: cumberlandpharma.com
Employees: 99
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
cumberland pharmaceuticals is a specialty pharmaceutical company whose mission is to acquire currently marketed and late-stage development pharmaceutical products and grow them through marketing to targeted, underserved physician segments. cumberland is dedicated to providing high quality products which address unmet medical needs.
Recent news